Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac
Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac
Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac
Submitted by
admin
on September 18, 2014 - 9:57am
Source:
Fierce Biotech
News Tags:
Boehringer Ingelheim
vaccines
CureVac
lung cancer
CV9202
Headline:
Boehringer pairs its lung cancer drug with a vaccine in $600M tie-up with CureVac
Do Not Allow Advertisers to Use My Personal information
